Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GREENBLATT

Showing results (351-360 of 1,248) with videos related to

Pageof 125
Sort By:
European Journal of Clinical Pharmacology|January 1, 1981
Effect of dose on bioavailability of oral digoxinH R Ochs, G Bodem, D J Greenblatt
Journal of Clinical Pharmacology|February 1, 1991
Differential side effect profile of triazolam versus flurazepam in elderly patients undergoing rehabilitation therapyE Woo, S M Proulx, D J Greenblatt
Arzneimittel-Forschung|December 1, 1986
Oxaprozin pharmacokinetics in patients with congestive heart failureH R Ochs, D J Greenblatt, M Knüchel
Journal of Analytical Toxicology|March 1, 1987
Measurement of clonazepam by electron-capture gas-liquid chromatography with application to single-dose pharmacokineticsL G Miller, H Friedman, D J Greenblatt
European Journal of Clinical Pharmacology|January 1, 1986
Effect of cirrhosis and renal failure on the kinetics of clotiazepamH R Ochs, D J Greenblatt, M Knüchel
The Journal of Pharmacy and Pharmacology|October 10, 2017
Mechanism of in-vitro inhibition of UGT1A1 by paritaprevirNovera Alam, Mia G Angeli, David J Greenblatt
Clinical Therapeutics|January 22, 2026
Time Trends in Prescribing of Anxiolytic, Sedative, and Hypnotic Drugs in the United StatesZhengzhe Yang, Richard I Shader, David J Greenblatt
Circulation|June 1, 1978
Impairment of antipyrine clearance in humans by propranololD J Greenblatt, K Franke, D H Huffman
Journal of Clinical Psychopharmacology|June 1, 1992
Nitrazepam clearance unimpaired in patients with renal insufficiencyH R Ochs, U Oberem, D J Greenblatt
Journal of Clinical Pharmacology|August 1, 1989
Impaired absorption of tetracycline by colestipol is not reversed by orange juiceH Friedman, D J Greenblatt, B W LeDuc
Pageof 125

Showing results (351-360 of 1,248) with videos related to

Sort By:
Pageof 125
European Journal of Clinical Pharmacology|January 1, 1981
Effect of dose on bioavailability of oral digoxinH R Ochs, G Bodem, D J Greenblatt
Journal of Clinical Pharmacology|February 1, 1991
Differential side effect profile of triazolam versus flurazepam in elderly patients undergoing rehabilitation therapyE Woo, S M Proulx, D J Greenblatt
Arzneimittel-Forschung|December 1, 1986
Oxaprozin pharmacokinetics in patients with congestive heart failureH R Ochs, D J Greenblatt, M Knüchel
Journal of Analytical Toxicology|March 1, 1987
Measurement of clonazepam by electron-capture gas-liquid chromatography with application to single-dose pharmacokineticsL G Miller, H Friedman, D J Greenblatt
European Journal of Clinical Pharmacology|January 1, 1986
Effect of cirrhosis and renal failure on the kinetics of clotiazepamH R Ochs, D J Greenblatt, M Knüchel
The Journal of Pharmacy and Pharmacology|October 10, 2017
Mechanism of in-vitro inhibition of UGT1A1 by paritaprevirNovera Alam, Mia G Angeli, David J Greenblatt
Clinical Therapeutics|January 22, 2026
Time Trends in Prescribing of Anxiolytic, Sedative, and Hypnotic Drugs in the United StatesZhengzhe Yang, Richard I Shader, David J Greenblatt
Circulation|June 1, 1978
Impairment of antipyrine clearance in humans by propranololD J Greenblatt, K Franke, D H Huffman
Journal of Clinical Psychopharmacology|June 1, 1992
Nitrazepam clearance unimpaired in patients with renal insufficiencyH R Ochs, U Oberem, D J Greenblatt
Journal of Clinical Pharmacology|August 1, 1989
Impaired absorption of tetracycline by colestipol is not reversed by orange juiceH Friedman, D J Greenblatt, B W LeDuc
Pageof 125